DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» GSK3B
GSK3B
Novel Driver Strength Index Highlights Important Cancer Genes in TCGA Pancanatlas Patients
GSK-3 and Tau: a Key Duet in Alzheimer's Disease
Role of Glycogen Synthase Kinase 3B in Rapamycin-Mediated Cell Cycle
Pairwise Network Mechanisms in the Host Signaling Response to Coxsackievirus B3 Infection
Maintaining Glycogen Synthase Kinase-3 Activity Is Critical for Mtor Kinase Inhibitors to Inhibit Cancer Cell Growth
GSK3 and Its Interactions with the PI3K/AKT/Mtor Signalling Network
Whole Transcriptomic Expression Differences in EBV Immortalized Versus Primary B-Cells
Stress Responsive Mir-31 Is a Major Modulator of Mouse
Activation of Diverse Signalling Pathways by Oncogenic PIK3CA Mutations
Signaling Cascade /Nfatc1 Β Through Regulating the GSK3 Akt Induces
Vimentin Is a Novel AKT1 Target Mediating Motility and Invasion
Gsk3b Is a Negative Regulator of the Transcriptional Coactivator MAML1 Mariana Saint Just Ribeiro, Magnus L
Deregulated Gsk3b Activity in Colorectal Cancer: Its Association with Tumor Cell Survival and Proliferation Q
Akt/PKB Kinase Phosphorylates Separately Thr212 and Ser214 of Tau Protein in Vitro
GSK3, a Master Kinase in the Regulation of Adult Stem Cell
Asian Indians Have Enhanced Skeletal Muscle Mitochondrial Capacity to Produce ATP in Association with Severe Insulin-Resistance
Tumor-Preventing Activity of Aspirin in Multiple Cancers Based on Bioinformatic Analyses
In Vitro and in Vivo Antitumor and Anti-Inflammatory Capabilities of the Novel GSK3 and CDK9 Inhibitor ABC1183 S
Top View
AKT As a Therapeutic Target for Cancer Mengqiu Song1,2, Ann M
Crosstalks of GSK3 Signaling with the Mtor Network and Effects on Targeted Therapy of Cancer T
Targeting GSK3 and Associated Signaling Pathways Involved in Cancer
Sulfhydration of AKT Triggers Tau-Phosphorylation by Activating Glycogen Synthase Kinase 3Β in Alzheimer's Disease
Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development–Review
INHIBITORS of CYCLIN-DEPENDENT KINASES AS CANCER THERAPEUTICS Authors
Datasheet: VMA00342
GSK3B Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties and Is a Novel Drug Target for Triple-Negative Breast Cancer
Signaling Through Cyclin D-Dependent Kinases
AKT1 Inhibits Epithelial-To-Mesenchymal
Prevalence of Germline Mutations in Cancer Susceptibility Genes In
Systemic Toxicity Reported for CDK8/19 Inhibitors CCT251921 and MSC2530818 Is Not Due to Target Inhibition
Glycogen Synthase Kinase 3B Mediates High Glucose-Induced Ubiquitination and Proteasome Degradation of Insulin Receptor Substrate 1
Lithium and Therapeutic Targeting of GSK-3
Stress Responsive Mir-31 Is a Major
The Discovery of a New Structural Class of Cyclin-Dependent Kinase Inhibitors, Aminoimidazo[1,2-A]Pyridines
Mithramycin Represses Basal and Cigarette Smoke-Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells
Remodeling of the Neuronal Microtubules in the Brain by Cdk5
Cdk5 Activity in the Brain – Multiple Paths of Regulation
Circulating Extracellular Rnas, Myocardial Remodeling, and Heart Failure in Patients with Acute Coronary Syndrome
Annotated Gene List HTG Edgeseq Autoimmune Panel
Table S11. up Or Down Regulated Genes in Tcof1 Over-Expressed
Identifying the Proteins to Which Small-Molecule Probes and Drugs Bind in Cells
Small Molecule Inhibitors of IKB Kinase Are Selectively Toxic for Subgroups of Diffuse Large B-Cell Lymphoma Defined by Gene Expression Profiling
Annotated Gene List HTG Edgeseq Immune Response Panel
BRAF Activates PAX3 to Control Muscle Precursor Cell Migration
Cyclin-Dependent Kinase 5 (CDK5)
Divergent and Convergent Roles for Kinases and Phosphatases in Neurofilament Dynamics
Source Target LCK ZAP70 EGFR ERBB2 RIPK1 RIPK3 RPS6KA3 MAPK1 SRC EGFR SRC PTK2 SYK LCK SRC ERBB2 SRC PTK2B SRC KDR FYN PRKCD
Competitive Kinase Enrichment Proteomics Reveals That Abemaciclib Inhibits Gsk3b and Activates WNT Signaling Emily M
Supplementary Information
Supplementary Experimental Procedures, Tables, Figures, and Data
MUC1 Antibody - C-Terminal Region (ARP41457 P050) Data Sheet
Glycogen Synthase Kinase 3Β in Cancer Biology and Treatment
Phosphoproteomics of MAPK Inhibition in BRAF-Mutated Cells and a Role for the Lethal Synergism of Dual BRAF and CK2 Inhibition
Alveolar-Capillary Barrier Co-Culture Model Schematic. Figure Generated with Biorender